Q

Qingdao Baheal Medical Inc
SZSE:301015

Watchlist Manager
Qingdao Baheal Medical Inc
SZSE:301015
Watchlist
Price: 27.18 CNY -1.52% Market Closed
Market Cap: 14.3B CNY
Have any thoughts about
Qingdao Baheal Medical Inc?
Write Note

Intrinsic Value

The intrinsic value of one Qingdao Baheal Medical Inc stock under the Base Case scenario is 45.59 CNY. Compared to the current market price of 27.18 CNY, Qingdao Baheal Medical Inc is Undervalued by 40%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
45.59 CNY
Undervaluation 40%
Intrinsic Value
Price
Q
Worst Case
Base Case
Best Case

Valuation History
Qingdao Baheal Medical Inc

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Qingdao Baheal Medical Inc cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Qingdao Baheal Medical Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

AI Assistant
AI Assistant
Ask me anything about Qingdao Baheal Medical Inc

Provide an overview of the primary business activities
of Qingdao Baheal Medical Inc.

What unique competitive advantages
does Qingdao Baheal Medical Inc hold over its rivals?

What risks and challenges
does Qingdao Baheal Medical Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Qingdao Baheal Medical Inc.

Provide P/S
for Qingdao Baheal Medical Inc.

Provide P/E
for Qingdao Baheal Medical Inc.

Provide P/OCF
for Qingdao Baheal Medical Inc.

Provide P/FCFE
for Qingdao Baheal Medical Inc.

Provide P/B
for Qingdao Baheal Medical Inc.

Provide EV/S
for Qingdao Baheal Medical Inc.

Provide EV/GP
for Qingdao Baheal Medical Inc.

Provide EV/EBITDA
for Qingdao Baheal Medical Inc.

Provide EV/EBIT
for Qingdao Baheal Medical Inc.

Provide EV/OCF
for Qingdao Baheal Medical Inc.

Provide EV/FCFF
for Qingdao Baheal Medical Inc.

Provide EV/IC
for Qingdao Baheal Medical Inc.

Show me price targets
for Qingdao Baheal Medical Inc made by professional analysts.

What are the Revenue projections
for Qingdao Baheal Medical Inc?

How accurate were the past Revenue estimates
for Qingdao Baheal Medical Inc?

What are the Net Income projections
for Qingdao Baheal Medical Inc?

How accurate were the past Net Income estimates
for Qingdao Baheal Medical Inc?

What are the EPS projections
for Qingdao Baheal Medical Inc?

How accurate were the past EPS estimates
for Qingdao Baheal Medical Inc?

What are the EBIT projections
for Qingdao Baheal Medical Inc?

How accurate were the past EBIT estimates
for Qingdao Baheal Medical Inc?

Compare the revenue forecasts
for Qingdao Baheal Medical Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Qingdao Baheal Medical Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Qingdao Baheal Medical Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Qingdao Baheal Medical Inc compared to its peers.

Compare the P/E ratios
of Qingdao Baheal Medical Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Qingdao Baheal Medical Inc with its peers.

Analyze the financial leverage
of Qingdao Baheal Medical Inc compared to its main competitors.

Show all profitability ratios
for Qingdao Baheal Medical Inc.

Provide ROE
for Qingdao Baheal Medical Inc.

Provide ROA
for Qingdao Baheal Medical Inc.

Provide ROIC
for Qingdao Baheal Medical Inc.

Provide ROCE
for Qingdao Baheal Medical Inc.

Provide Gross Margin
for Qingdao Baheal Medical Inc.

Provide Operating Margin
for Qingdao Baheal Medical Inc.

Provide Net Margin
for Qingdao Baheal Medical Inc.

Provide FCF Margin
for Qingdao Baheal Medical Inc.

Show all solvency ratios
for Qingdao Baheal Medical Inc.

Provide D/E Ratio
for Qingdao Baheal Medical Inc.

Provide D/A Ratio
for Qingdao Baheal Medical Inc.

Provide Interest Coverage Ratio
for Qingdao Baheal Medical Inc.

Provide Altman Z-Score Ratio
for Qingdao Baheal Medical Inc.

Provide Quick Ratio
for Qingdao Baheal Medical Inc.

Provide Current Ratio
for Qingdao Baheal Medical Inc.

Provide Cash Ratio
for Qingdao Baheal Medical Inc.

What is the historical Revenue growth
over the last 5 years for Qingdao Baheal Medical Inc?

What is the historical Net Income growth
over the last 5 years for Qingdao Baheal Medical Inc?

What is the current Free Cash Flow
of Qingdao Baheal Medical Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Qingdao Baheal Medical Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Qingdao Baheal Medical Inc

Current Assets 5.1B
Cash & Short-Term Investments 1.7B
Receivables 2.4B
Other Current Assets 1B
Non-Current Assets 906.7m
Long-Term Investments 307.6m
PP&E 419m
Intangibles 99.1m
Other Non-Current Assets 81m
Current Liabilities 2.6B
Accounts Payable 605.1m
Accrued Liabilities 110.4m
Short-Term Debt 1.6B
Other Current Liabilities 229m
Non-Current Liabilities 828m
Long-Term Debt 832.3m
Other Non-Current Liabilities -4.2m
Efficiency

Earnings Waterfall
Qingdao Baheal Medical Inc

Revenue
7.5B CNY
Cost of Revenue
-5.2B CNY
Gross Profit
2.3B CNY
Operating Expenses
-1.3B CNY
Operating Income
973m CNY
Other Expenses
-250.5m CNY
Net Income
722.5m CNY

Free Cash Flow Analysis
Qingdao Baheal Medical Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Qingdao Baheal Medical Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Positive 3-Year Average ROE
Exceptional ROE
Positive 3-Year Average ROIC
Positive Gross Profit
60/100
Profitability
Score

Qingdao Baheal Medical Inc's profitability score is 60/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Qingdao Baheal Medical Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
64/100
Solvency
Score

Qingdao Baheal Medical Inc's solvency score is 64/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Qingdao Baheal Medical Inc

Wall Street analysts forecast Qingdao Baheal Medical Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Qingdao Baheal Medical Inc is 48.96 CNY with a low forecast of 48.48 CNY and a high forecast of 50.4 CNY.

Lowest
Price Target
48.48 CNY
78% Upside
Average
Price Target
48.96 CNY
80% Upside
Highest
Price Target
50.4 CNY
85% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Qingdao Baheal Medical Inc?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Qingdao Baheal Medical Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Qingdao Baheal Medical Inc

Country

China

Industry

Health Care

Market Cap

14.3B CNY

Dividend Yield

2.8%

Description

Qingdao Baheal Medical, Inc. engages in the provision of marketing services for pharmaceutical product manufacturers. The company is headquartered in Qingdao, Shandong and currently employs 2,396 full-time employees. The company went IPO on 2021-06-30. The firm provides brand operation, wholesale distribution and retail services for pharmaceutical products. Its brand operation services include consumer education, product academic promotion, marketing planning, business contacts, product distribution, flow tracking and supply chain management services. The firm's wholesale distribution business mainly centers on Qingdao and Beijing, and radiates second-level and above hospitals, community clinics and pharmacies in surrounding cities. Its wholesale distribution products include medicines, Chinese herbal medicine pieces, medical equipment, diagnostic reagents, medical consumables, among others. The firm mainly conducts its business within domestic market.

Contact

SHANDONG
Qingdao
Baiyang Health Technology Park, No. 88 Kaifeng Road, Shibei District
+8653267773303
www.baheal.cn

IPO

2021-06-30 00:00:00

Employees

2 396

Officers

Chairman & GM
Mr. Gang Fu
Deputy GM, CFO, Secretary & Director
Mr. Guoqiang Wang
Deputy GM & Director
Ms. Yuan Zhang
Accounting Chief Manager
Hui Xu

See Also

Discover More
What is the Intrinsic Value of one Qingdao Baheal Medical Inc stock?

The intrinsic value of one Qingdao Baheal Medical Inc stock under the Base Case scenario is 45.59 CNY.

Is Qingdao Baheal Medical Inc stock undervalued or overvalued?

Compared to the current market price of 27.18 CNY, Qingdao Baheal Medical Inc is Undervalued by 40%.

Back to Top